Oliver Hill
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy.
Journal: Frontiers in immunology
Published: February 06, 2023
Nanoscale FasL Organization on DNA Origami to Decipher Apoptosis Signal Activation in Cells.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 22, 2021
Concepts for agonistic targeting of CD40 in immuno-oncology.
Journal: Human vaccines & immunotherapeutics
Published: August 13, 2019
HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.
Journal: Journal for immunotherapy of cancer
Published: May 06, 2019
The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 02, 2018
A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity.
Journal: Frontiers in oncology
Published: June 27, 2018
The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells.
Journal: Cell death & disease
Published: October 19, 2017
hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma.
Journal: Cell death discovery
Published: April 14, 2016
Peripheral monocytes are functionally altered and invade the CNS in ALS patients.
Journal: Acta neuropathologica
Published: October 02, 2015
Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro.
Journal: Anti-cancer drugs
Published: April 09, 2015
CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma.
Journal: Cell death and differentiation
Published: January 27, 2014
Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice.
Journal: The Journal of experimental medicine
Published: November 21, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026